Multicenter double blind randomized placebo controlled clinical trial of minoxidil gel in the treatment of alopecia areata

YANG Shu-xia,ZHAO Guang,LI Chun-yang,ZHU Xue-jun
DOI: https://doi.org/10.3969/j.issn.1001-6821.2006.02.003
2006-01-01
Abstract:Objective To compare the efficacy and safety of 2.2% minoxidil gel and placebo in the treatment of alopecia areata. Methods A double-bind, randomized, placebo-controlled, multicenter trial was conducted.The patients with alopecia areata applied 2.2% minoxidil gel or placebo twice daily for 3 months.Results One hundred and twenty eight cases were taken into the analysis of efficacy and safety including 66 cases for 2.2% minoxidil gel and 62 cases for placebo. The time hair began to regrow, the length of hair growth, the decrease of bald area and the overall evaluation in minoxidil group were all significantly better than those in placebo group. Adverse reaction were observed in 7.58%, 6.45 % of patients in the two groups, and there was not significant difference between two groups. Conclusion 2.2% minoxidil gel was effective and safe in the treatment of alopecia areata.
What problem does this paper attempt to address?